These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24842252)

  • 1. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy.
    Ma J; Chadban SJ; Zhao CY; Chen X; Kwan T; Panchapakesan U; Pollock CA; Wu H
    PLoS One; 2014; 9(5):e97985. PubMed ID: 24842252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
    Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
    Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.
    Lin M; Yiu WH; Wu HJ; Chan LY; Leung JC; Au WS; Chan KW; Lai KN; Tang SC
    J Am Soc Nephrol; 2012 Jan; 23(1):86-102. PubMed ID: 22021706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
    Liu P; Li F; Qiu M; He L
    Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
    Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
    Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy.
    Jialal I; Major AM; Devaraj S
    J Diabetes Complications; 2014; 28(6):755-61. PubMed ID: 25116192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M; Liu M; Xiong M; Gong J; Tan X
    J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
    Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K
    Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-874 alleviates renal injury and inflammatory response in diabetic nephropathy through targeting toll-like receptor-4.
    Yao T; Zha D; Gao P; Shui H; Wu X
    J Cell Physiol; 2018 Jan; 234(1):871-879. PubMed ID: 30171701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation.
    Sun LN; Yang ZY; Lv SS; Liu XC; Guan GJ; Liu G
    Int Immunopharmacol; 2014 Nov; 23(1):236-46. PubMed ID: 25196431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Angiopoietin-Like Protein 2 Ameliorates Diabetic Nephropathy by Inhibiting TLR4.
    Yang S; Zhang J; Wang S; Shi J; Zhao X
    Cell Physiol Biochem; 2017; 43(2):685-696. PubMed ID: 28946139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy.
    Wei TT; Yang LT; Guo F; Tao SB; Cheng L; Huang RS; Ma L; Fu P
    Acta Pharmacol Sin; 2021 Feb; 42(2):252-263. PubMed ID: 32948825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.
    Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS
    Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury.
    Lim AK; Ma FY; Nikolic-Paterson DJ; Kitching AR; Thomas MC; Tesch GH
    Diabetologia; 2010 Aug; 53(8):1772-82. PubMed ID: 20422398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy.
    Devaraj S; Tobias P; Kasinath BS; Ramsamooj R; Afify A; Jialal I
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1796-804. PubMed ID: 21617141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy.
    Du L; Chen Y; Shi J; Yu X; Zhou J; Wang X; Xu L; Liu J; Gao J; Gu X; Wang T; Yin Z; Li C; Yan M; Wang J; Yin X; Lu Q
    Metabolism; 2023 Jul; 144():155376. PubMed ID: 36521551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalin suppresses renal fibrosis through microRNA-124/TLR4/NF-κB axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells.
    Zhang S; Xu L; Liang R; Yang C; Wang P
    J Physiol Biochem; 2020 Aug; 76(3):407-416. PubMed ID: 32500512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice.
    Zhang QY; Xu SJ; Qian JC; Yang LB; Chen PQ; Wang Y; Hu X; Zhang YL; Luo W; Liang G
    Acta Pharmacol Sin; 2022 Feb; 43(2):354-366. PubMed ID: 34552217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.